What Does Bicara Therapeutics CEO Sale Signal Investors
When a biotech CEO sells shares after exercising options, investors rightly pause to interpret the move. This article...
Compare dividend ETF charges and learn which fees apply to different ETF options, helping you understand total costs and make smarter investment choices.
21,758 articlesWhen a biotech CEO sells shares after exercising options, investors rightly pause to interpret the move. This article...
A large open-market sale by Indivior's Chief Scientific Officer sparked questions about future risk and long-term val...
Toast stock could be a rare restaurant technology winner, built on a scalable platform. This analysis lays out why lo...
Palantir stock has cooled after a run of gains and is trading near its 52-week low. This guide explores what that mea...
David Cordani is stepping aside as Cigna's CEO to become executive chairman, ending a 17‑year run that propelled the ...
A Qualys director recently sold shares worth about $104,000 in an open-market move. Learn how to interpret insider sa...
Micron Technology has delivered a stunning 770% year-to-date surge as AI-driven memory demand intensifies. The rally ...
In Q1 2026, Alphabet leverages cloud and AI families to expand, while Meta doubles down on ads. The split underscores...
CoreWeave has turbocharged its AI compute backlog ahead of a Nasdaq-100 debut, placing the stock under fresh scrutiny...
New Bank of America analysis suggests the miserable k-shaped economy might be fading as lower-income households incre...
The memory market has reshaped profits for chip makers and device companies. This article explains how Micron benefit...
With rates stabilizing in the mid-6% range, the housing market braces for a steadier second half of 2026. Pending sal...